Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 123 results for "warner chilcott"

Warner Chilcott Partnering Deals and Alliances 2010-2016 - Res...

Research and Markets has announced the addition of the "Warner Chilcott Partnering Deals and Alliances 2010 to 2016" company profile to their offering. The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the ... 4 Traders, 2 weeks ago
[x]  

1 images for "warner chilcott"

Healthcare Finance News, 7 months ago
Washington Post

Three Former Warner Chilcott District Managers Prosecuted for HIPAA Violations

The United States Attorney's Office for the District of Massachusetts recently announced that three former district managers of the pharmaceutical firm Warner Chilcott have been sentenced for violating the Health Insurance Portability and ...
 JD Supra2 weeks ago Protect Your Patients' Information  Advance for Respiratory Care & Sleep Medicine1 month ago Ex-Warner sales exec gets probation, $10K fine in prior auth HIPAA case  FiercePharma1 month ago Going Out Guide for the District of Columbia, Dec. 1-7, 2016  Washington Post3 days ago

Merck Sharp & Dohme B.V. v. Warner Chilcott Co., LLC

Case Name: , Civ. No. 13-2088-GMS, 2016 U.S. Dist. LEXIS 114419 (D. Del. Aug 26, 2016) (Sleet, J.) Drug Product and Patent(s)-in-Suit: NuvaRing® (etonogestrel / ethinyl estradiol); U.S. Patent No. 5,989,581 (the 581 patent) Nature of the Case and ...
 JD Supra3 weeks ago

Third Circuit Upholds Dismissal of Doryx Product Hopping Suit

, the Third Circuit issued an opinion in Mylan v. Warner Chilcott, upholding the Eastern District of Pennsylvania's holding on summary judgement that Defendants product hopping conduct did not violate the Sherman Act.[1] Product hopping generally ...
 JD Supra1 month ago 3rd Circuit Weighs In On Product-Hopping  JD Supra4 weeks ago Third Circuit Focuses on Relevant Product Market and Lack of Anticompetitive Conduct in Doryx Product-Hopping Case  JD Supra1 month ago Doryx: Third Circuit Affirms Dismissal of Product Hopping Claim  JD Supra2 months ago

Allergan: Low Enough To Like, Or Valeant-Lite?

Overview Allergan plc (NYSE: AGN ) now operates as "legacy Allergan" did - as a branded medical products company. AGN markets the injectable drug Botox, specialized topical eyedrops such as Restasis and glaucoma formulations; intra-ocular ...
 Seeking Alpha2 days ago Allergan: Trading at a Low Earnings Multiple  Yahoo! Finance3 weeks ago

4 - Avista Acquisition Corp. (0001661187) (Reporting)

Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001140361-16-088066 Filing Date 2016-11-29 2016-11-29 16:38:01 Period of Report 2016-11-25 Filing Date Changed 2016-11-29 Document Format Files ...
 SEC Filings4 days ago 3 - Avista Acquisition Corp. (0001661187) (Reporting)  SEC Filings1 month ago 3 - Avista Healthcare Public Acquisition Corp. (0001661181) (Issuer)  SEC Filings1 month ago

4 - Avista Acquisition, LLC (0001686388) (Reporting)

Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001140361-16-088066 Filing Date 2016-11-29 2016-11-29 16:38:01 Period of Report 2016-11-25 Filing Date Changed 2016-11-29 Document Format Files ...
 SEC Filings4 days ago 3 - Avista Acquisition, LLC (0001686388) (Reporting)  SEC Filings1 month ago

4 - Dean Thompson (0001069096) (Reporting)

Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001140361-16-088066 Filing Date 2016-11-29 2016-11-29 16:38:01 Period of Report 2016-11-25 Filing Date Changed 2016-11-29 Document Format Files ...
 SEC Filings4 days ago 3 - Dean Thompson (0001069096) (Reporting)  SEC Filings1 month ago 3 - Burgstahler David F (0001374179) (Reporting)  SEC Filings1 month ago

Europe Imatinib Mesylate Market Report to 2021

In depth analysis of Europe Imatinib Mesylate Market is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others. The Europe Imatinib Mesylate Market research report is a resource, which provides technical and ...
 Before It's News5 days ago

New Antitrust Risks from Introducing New Drugs

By and David Burns Recent court decisions and statements by federal and state antitrust enforcers regarding product hopping— the practice of introducing a new version of an existing drug allegedly to discourage generic substitution—raise ...
 JD Supra1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less